MedTrace Logo

Predictors of Poor Bowel Cleansing and Capsule Endoscopy (CEPREDICT)

NCT03933371 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 403

Last updated 2019-05-07

No results posted yet for this study

Summary

The main purpose of the study is to determine risk factors of poor bowel cleansing in patients referred for colon capsule endoscopy (CCE) examination. Patients will be prepared with polyethylene glycol (PEG), and a booster by using oral low volume sodium phosphate (NaP) and sodium-amidotrizoate and meglumine-amidotrizoate (Gastrografin ®) The investigators also will try to design a predictive score of poor bowel cleansing and to validate the Bowel cleansing score designed by Leighton and modified by Spada

Conditions

  • Colon Adenoma

Interventions

DEVICE

Colon Capsule Endoscopy

The capsule endoscopy will be ingested by the participant. This device captures images along the large bowel. This images are stored in an external memory and afterwards they are downloaded in a computer

Sponsors & Collaborators

  • Hospital Universitario de Canarias

    lead OTHER

Principal Investigators

  • Antonio Z Gimeno Garcia, MD, PhD · Hospital Universitario de Canarias

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-31
Primary Completion
2020-11-30
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03933371 on ClinicalTrials.gov